Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedFeb 01, 2026
DataAggregated Company Financials
Companies133
  • 7D-2.8%
  • 3M12.2%
  • 1Y-17.5%
  • YTD5.7%

Over the last 7 days, the market has dropped 2.8%, driven by a loss of 7.0% in the Healthcare sector. Meanwhile, the Industrials sector has outperformed, gaining 3.5% in that time. The market has dropped 17% in the last year. As for the next few years, earnings are expected to grow by 5.3% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 01 Feb 2026DKK 4.4tDKK 1.9tDKK 260.8b16.8x17x2.3x
Tue, 30 Dec 2025DKK 4.2tDKK 1.9tDKK 260.6b16.2x16x2.1x
Thu, 27 Nov 2025DKK 4.0tDKK 2.0tDKK 262.2b15x15.3x2.1x
Sat, 25 Oct 2025DKK 4.1tDKK 2.0tDKK 287.0b15.3x14.2x2.1x
Mon, 22 Sep 2025DKK 4.1tDKK 1.9tDKK 287.2b15x14.3x2.1x
Wed, 20 Aug 2025DKK 4.0tDKK 1.9tDKK 285.0b15.3x14.2x2.1x
Fri, 18 Jul 2025DKK 4.3tDKK 1.9tDKK 262.5b15.7x16.5x2.3x
Sun, 15 Jun 2025DKK 4.8tDKK 1.9tDKK 262.6b15.3x18.3x2.6x
Tue, 13 May 2025DKK 4.4tDKK 1.9tDKK 267.7b15.7x16.4x2.3x
Thu, 10 Apr 2025DKK 3.9tDKK 1.9tDKK 260.4b12.8x14.9x2.1x
Sat, 08 Mar 2025DKK 5.2tDKK 1.9tDKK 260.4b14.5x19.9x2.8x
Mon, 03 Feb 2025DKK 5.2tDKK 1.8tDKK 238.3b14.1x21.7x2.8x
Wed, 01 Jan 2025DKK 5.3tDKK 1.8tDKK 238.4b13.8x22x2.9x
Fri, 29 Nov 2024DKK 5.8tDKK 1.8tDKK 237.7b14.2x24.5x3.2x
Sun, 27 Oct 2024DKK 6.0tDKK 1.7tDKK 180.2b15.3x33.3x3.4x
Tue, 24 Sep 2024DKK 6.4tDKK 1.7tDKK 180.0b16.1x35.5x3.7x
Thu, 22 Aug 2024DKK 6.5tDKK 1.7tDKK 180.5b16.8x36.2x3.8x
Sat, 20 Jul 2024DKK 6.5tDKK 1.7tDKK 185.3b15.3x35.3x3.8x
Mon, 17 Jun 2024DKK 6.9tDKK 1.7tDKK 184.8b15.3x37.4x4x
Wed, 15 May 2024DKK 6.6tDKK 1.7tDKK 184.3b15.2x35.8x3.9x
Fri, 12 Apr 2024DKK 6.4tDKK 1.7tDKK 192.8b15.2x33x3.7x
Sun, 10 Mar 2024DKK 6.6tDKK 1.7tDKK 192.0b13.3x34.2x3.8x
Tue, 06 Feb 2024DKK 6.1tDKK 1.8tDKK 225.2b12.8x27x3.4x
Thu, 04 Jan 2024DKK 5.6tDKK 1.8tDKK 216.9b13.5x25.7x3.1x
Sat, 02 Dec 2023DKK 5.4tDKK 1.8tDKK 216.9b13.7x25x3.1x
Mon, 30 Oct 2023DKK 5.1tDKK 1.9tDKK 302.7b12.4x17x2.8x
Wed, 27 Sep 2023DKK 5.3tDKK 1.9tDKK 284.7b13x18.5x2.8x
Fri, 25 Aug 2023DKK 5.4tDKK 1.9tDKK 282.8b13x19x2.9x
Sun, 23 Jul 2023DKK 5.1tDKK 1.9tDKK 319.5b13.4x16.1x2.7x
Tue, 20 Jun 2023DKK 5.1tDKK 1.9tDKK 322.1b13.8x15.7x2.6x
Thu, 18 May 2023DKK 5.3tDKK 1.9tDKK 323.1b14.2x16.3x2.7x
Sat, 15 Apr 2023DKK 5.1tDKK 1.9tDKK 342.1b15.1x14.9x2.7x
Mon, 13 Mar 2023DKK 4.7tDKK 1.9tDKK 347.6b14x13.6x2.5x
Wed, 08 Feb 2023DKK 4.7tDKK 1.9tDKK 356.5b13.8x13.2x2.5x
Price to Earnings Ratio

13.2x


Total Market Cap: DKK 4.7tTotal Earnings: DKK 356.5bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.2x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 17.0x which is lower than its 3-year average PE of 22.2x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 9.9% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market-2.76%
Energy6.36%
Industrials3.54%
Utilities2.79%
Consumer Staples0.68%
Real Estate0.48%
Consumer Discretionary0.33%
Financials-0.078%
Telecom-0.64%
Tech-3.00%
Materials-4.42%
Healthcare-7.03%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 52.5x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 55.6% which is higher than its past year's earnings decline of 17.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 56% over the next 5 years.
  • This is better than its past earnings decline of 17% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 35% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
MAERSK B A.P. Møller - MærskDKK 15.63k8.5%
+DKK 17.5b		46.8%PE7.4xIndustrials
VWS Vestas Wind SystemsDKK 191.656.9%
+DKK 12.2b		93.7%PE27.1xIndustrials
ORSTED ØrstedDKK 141.602.8%
+DKK 5.1b		-49.1%PS2.6xUtilities
DSV DSVDKK 1.77k1.2%
+DKK 4.8b		23.2%PE44.1xIndustrials
DANSKE Danske BankDKK 321.500.7%
+DKK 1.7b		49.5%PB1.5xFinancials
See more

Market Insights

Header cover image
Why longer lifespans could reshape portfolios 🧓
Stella Ong avatar
Stella Ong
|
|
There’s the Great Wealth Transfer and Longevity Effect. Here’s how our changing demographic and wealth is set to shape future markets.
Continue reading
How to invest when commodity prices get messy ⚖️
Last Week

How to invest when commodity prices get messy ⚖️

Latest News

NOVO B
DKK 369.55
Novo Nordisk
7D
-7.9%
1Y
-39.1%
DEMANT
DKK 220.40
Demant
7D
-4.2%
1Y
-24.0%
HLUN B
DKK 42.12
H. Lundbeck
7D
-7.6%
1Y
-4.4%
CARL B
DKK 853.00
Carlsberg
7D
0.9%
1Y
13.0%

Many Still Looking Away From Carlsberg A/S (CPH:CARL B)

Jan 30
Many Still Looking Away From Carlsberg A/S (CPH:CARL B)
ORSTED
DKK 141.60
Ørsted
7D
2.8%
1Y
-49.1%
ALK B
DKK 207.60
ALK-Abelló
7D
-5.4%
1Y
27.5%
DSV
DKK 1,769.00
DSV
7D
1.2%
1Y
23.2%

DSV: Freight Cycle Recovery Hopes And Margin Discipline Will Shape Future Returns

Analysts have raised their fair value estimate for DSV from DKK 1,825.84 to DKK 1,901.25. This revision reflects higher Street price targets and updated assumptions for the discount rate, revenue growth, profit margins, and future P/E multiples.
COLO B
DKK 536.00
Coloplast
7D
-1.1%
1Y
-35.4%

Coloplast A/S' (CPH:COLO B) P/E Is On The Mark

Jan 25
Coloplast A/S' (CPH:COLO B) P/E Is On The Mark
MAERSK B
DKK 15,630.00
A.P. Møller - Mærsk
7D
8.5%
1Y
46.8%

MAERSK B: Prolonged Transport Weakness Will Outweigh Profit Margins Going Forward

Analysts have trimmed their fair value estimate for A.P. Møller - Mærsk from DKK 11,991.74 to DKK 11,589.21, reflecting more cautious price targets after several recent downgrades and mixed target revisions across major banks. Analyst Commentary Recent research on A.P. Møller - Mærsk points to a split view, with some analysts trimming targets and ratings while others still see room for value at different price levels.
NKT
DKK 826.00
NKT
7D
2.7%
1Y
71.2%

NKT: Order Backlog Execution Will Support Sector-Leading Margins By 2028

Analysts have trimmed their fair value estimate for NKT to DKK 1,008 from DKK 1,097, reflecting updated views on growth, profitability and valuation multiples following recent downgrades and mixed price target revisions across the Street. Analyst Commentary Street research on NKT has been mixed recently, with some firms turning more cautious on the shares while others see enough execution progress and market opportunity to justify higher valuation benchmarks.
DANSKE
DKK 321.50
Danske Bank
7D
0.7%
1Y
49.5%

DANSKE: Future Repricing Risk Seen As Earnings Outpace Lower P E Assumptions

Analysts have lifted their price targets on Danske Bank, with recent moves such as DKK 352 to DKK 358, DKK 308 to DKK 319 and DKK 275 to DKK 295. These changes reflect updated views on revenue growth, profit margins and a lower assumed future P/E multiple in the refreshed valuation work.
VWS
DKK 191.65
Vestas Wind Systems
7D
6.9%
1Y
93.7%

VWS: Higher Price View Will Face Pressure From Execution And Margin Risks

Analysts have lifted their price target on Vestas Wind Systems, with one recent move taking it to DKK 173 from DKK 164. The change reflects updates to fair value assumptions, discount rate, revenue growth expectations, profit margin outlook and future P/E inputs.
GMAB
DKK 2,022.00
Genmab
7D
-5.1%
1Y
41.9%

GMAB: Phase 3 Setback And 2026 Readout Will Shape Market Outlook

Genmab’s analyst price target has been lifted by roughly DKK 100 to reflect updated expectations around slightly higher revenue growth and profit margin assumptions, as analysts point to recent target increases from DKK 2,000 to DKK 2,400 and DKK 2,500 as support for a higher fair value range. Analyst Commentary Recent Street research on Genmab reflects a generally constructive stance, with higher price targets and continued attention on upcoming clinical milestones.
TRMD A
DKK 154.70
TORM
7D
6.4%
1Y
8.0%
CHEMM
DKK 609.50
ChemoMetec
7D
-10.9%
1Y
8.8%
NSIS B
DKK 385.70
Novozymes
7D
-4.6%
1Y
-6.7%